Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T20:56:47.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision v3.3.2 was added and Revision v3.2.0 was removed from the history; this is a minor page-history update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:23:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A funding status notice was removed from the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T07:13:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Version 1 shows no substantive changes to the study data. The screenshots illustrate visual/UI differences rather than any data updates.
    Difference
    0.1%
    Check dated 2025-11-03T21:20:21.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    13%
    Check dated 2025-10-06T05:50:47.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:09:50.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.